Publication | Closed Access

Randomized Phase Ii Study of Mehd7945A (Mehd) Vs Cetuximab (Cet) in >= 2Nd-Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck (Rmscchn) Progressive On/After Platinum-Based Chemotherapy (Ptct)

Malignant DiseaseMedicinePathologyPhase Ii StudyVs CetuximabMolecular OncologyHead And Neck CancerCancer TreatmentNeck OncologyRadiation OncologyOncologyCancer TherapeuticsCancer ResearchHealth Sciences